This Website Is Currently Under Construction
The website will contain promotional information on Defitelio▼ (defibrotide) and has been developed in-line with EU marketing authorisation. Please consult local prescribing information for further information. In the meantime, if you are a Healthcare Professional outside of the US you can access the additional eLearning modules for HCPs below.
By entering this site, you are confirming that you are a healthcare professional within your selected country.
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national reporting system. Adverse events should also be reported to Jazz Pharmaceuticals by email to aereporting@jazzpharma.com or by fax to +44(0) 1865 598765
▼ - This medicinal product is subject to additional monitoring